The Landmarks of OncoPharm series returns to discuss 2 pivotal trials that ushered in the age of aprepitant and NK-1 receptor anagonists for CINV.

Aprepitant in HEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2003.01.095

Aprepitant in MEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2005.09.050

The Landmarks of OncoPharm series returns to discuss 2 pivotal trials that ushered in the age of aprepitant and NK-1 receptor anagonists for CINV. Aprepitant in HEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2003.01.095 Aprepitant in MEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2005.09.050

Emend's Emergence

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Science

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Share Emend's Emergence

Sign up to save your podcasts

Emend's Emergence

Emend's Emergence

More shows like OncoPharm

JAMA Clinical Reviews

The Daily

Up First from NPR

Armchair Expert with Dax Shepard

ASCO Guidelines

The Peter Attia Drive

OncLive® On Air

Raising Good Humans

Oncology Today with Dr Neil Love

Huberman Lab

The Money with Katie Show

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

WolverHeme Happy Hour

Good Hang with Amy Poehler